Emily Gomme

527 total citations
14 papers, 280 citations indexed

About

Emily Gomme is a scholar working on Epidemiology, Infectious Diseases and Virology. According to data from OpenAlex, Emily Gomme has authored 14 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Infectious Diseases and 5 papers in Virology. Recurrent topics in Emily Gomme's work include Respiratory viral infections research (6 papers), Influenza Virus Research Studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Emily Gomme is often cited by papers focused on Respiratory viral infections research (6 papers), Influenza Virus Research Studies (4 papers) and Pneumonia and Respiratory Infections (4 papers). Emily Gomme collaborates with scholars based in United States, Germany and United Kingdom. Emily Gomme's co-authors include Matthias J. Schnell, Christoph Wirblich, Celestine N. Wanjalla, Alejandra Gurtman, Agnieszka Zareba, Daniel A. Scott, Edward E. Walsh, Kathrin U. Jansen, David Cooper and Ann R. Falsey and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and Journal of Virology.

In The Last Decade

Emily Gomme

13 papers receiving 270 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily Gomme United States 7 186 142 73 37 32 14 280
Céline Boschi France 11 99 0.5× 170 1.2× 45 0.6× 20 0.5× 70 2.2× 29 279
Cyril Masante France 8 276 1.5× 141 1.0× 33 0.5× 12 0.3× 79 2.5× 10 357
Stephanie Ascough United Kingdom 11 120 0.6× 110 0.8× 38 0.5× 25 0.7× 114 3.6× 18 309
Bhagwat Gunale India 7 71 0.4× 64 0.5× 78 1.1× 17 0.5× 34 1.1× 12 178
María Piñana Spain 13 202 1.1× 212 1.5× 13 0.2× 35 0.9× 69 2.2× 27 353
Mariarosaria Del Sorbo Italy 5 106 0.6× 80 0.6× 41 0.6× 26 0.7× 42 1.3× 6 212
Alberto Ospina Stella Australia 9 57 0.3× 136 1.0× 30 0.4× 10 0.3× 79 2.5× 14 259
Agnès Petit‐Camurdan France 8 161 0.9× 87 0.6× 22 0.3× 60 1.6× 105 3.3× 9 352
Joel Paul United Kingdom 5 48 0.3× 140 1.0× 64 0.9× 11 0.3× 17 0.5× 9 224
Tracey M. Doyle Canada 10 231 1.2× 158 1.1× 115 1.6× 16 0.4× 77 2.4× 11 395

Countries citing papers authored by Emily Gomme

Since Specialization
Citations

This map shows the geographic impact of Emily Gomme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Gomme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Gomme more than expected).

Fields of papers citing papers by Emily Gomme

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Gomme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Gomme. The network helps show where Emily Gomme may publish in the future.

Co-authorship network of co-authors of Emily Gomme

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Gomme. A scholar is included among the top collaborators of Emily Gomme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Gomme. Emily Gomme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Branche, Angela R, Mark J. Mulligan, Orlando Puente, et al.. (2025). A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults. Vaccines. 13(4). 383–383. 3 indexed citations
2.
Fitzpatrick, David, Lisa A. Jackson, Graham Crowther, et al.. (2025). Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine. New England Journal of Medicine. 393(20). 2001–2011. 3 indexed citations
3.
Lindert, Kelly, Alex Mann, Anita Geevarughese, et al.. (2025). Human Challenge Trial of a Nucleoside-Modified Messenger Ribonucleic Acid Influenza Vaccine. NEJM Evidence. 4(12). EVIDoa2500087–EVIDoa2500087. 1 indexed citations
4.
5.
Saukkoriipi, Annika, Natalie C. Silmon de Monerri, Maija Toropainen, et al.. (2024). Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control study. The Lancet Microbe. 5(7). 689–696. 5 indexed citations
6.
Walsh, Edward E., Ann R. Falsey, Agnieszka Zareba, et al.. (2024). Respiratory Syncytial Virus Prefusion F Vaccination: Antibody Persistence and Revaccination. The Journal of Infectious Diseases. 230(4). e905–e916. 6 indexed citations
7.
Simões, Eric A. F., Shabir A. Madhi, Conrado J. Llapur, et al.. (2022). 91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations
8.
Falsey, Ann R., Edward E. Walsh, Daniel A. Scott, et al.. (2021). Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine. The Journal of Infectious Diseases. 225(12). 2056–2066. 58 indexed citations
9.
Walsh, Edward E., Ann R. Falsey, Daniel A. Scott, et al.. (2021). A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine. The Journal of Infectious Diseases. 225(8). 1357–1366. 67 indexed citations
10.
Wanjalla, Celestine N., Emily Gomme, Christoph Wirblich, et al.. (2013). Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA Viruses. PLoS ONE. 8(6). e67123–e67123. 13 indexed citations
11.
Gomme, Emily, Christoph Wirblich, Sankar Addya, Glenn F. Rall, & Matthias J. Schnell. (2012). Immune Clearance of Attenuated Rabies Virus Results in Neuronal Survival with Altered Gene Expression. PLoS Pathogens. 8(10). e1002971–e1002971. 41 indexed citations
12.
Gomme, Emily, Celestine N. Wanjalla, Christoph Wirblich, & Matthias J. Schnell. (2011). Rabies Virus as a Research Tool and Viral Vaccine Vector. Advances in virus research. 79. 139–164. 31 indexed citations
13.
14.
Gomme, Emily, et al.. (2010). Characterization of a Single-Cycle Rabies Virus-Based Vaccine Vector. Journal of Virology. 84(6). 2820–2831. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Céline Boschi Breakdown of academic impact, for papers by Cyril Masante Breakdown of academic impact, for papers by Stephanie Ascough Breakdown of academic impact, for papers by Bhagwat Gunale Breakdown of academic impact, for papers by María Piñana Breakdown of academic impact, for papers by Mariarosaria Del Sorbo Breakdown of academic impact, for papers by Alberto Ospina Stella Breakdown of academic impact, for papers by Agnès Petit‐Camurdan Breakdown of academic impact, for papers by Joel Paul Breakdown of academic impact, for papers by Tracey M. Doyle
Rankless by CCL
2026